Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study is being done to analyze the safety, tolerability, and efficacy of treatment using combination of SAM and anti-PD-1/PDL1 antibodies for patients with advanced hepatocellular carcinoma.
Epistemonikos ID: 1367e5265117bff34a4edbe88781ec9f9e54a288
First added on: May 14, 2024